<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-11-22" modified="2020-10-07" version="195">
<accession>O00267</accession>
<accession>O43279</accession>
<accession>Q59G52</accession>
<accession>Q99639</accession>
<name>SPT5H_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transcription elongation factor SPT5</fullName>
<shortName>hSPT5</shortName>
</recommendedName>
<alternativeName>
<fullName>DRB sensitivity-inducing factor 160 kDa subunit</fullName>
<shortName>DSIF p160</shortName>
</alternativeName>
<alternativeName>
<fullName>DRB sensitivity-inducing factor large subunit</fullName>
<shortName>DSIF large subunit</shortName>
</alternativeName>
<alternativeName>
<fullName>Tat-cotransactivator 1 protein</fullName>
<shortName>Tat-CT1 protein</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">SUPT5H</name>
<name type="synonym">SPT5</name>
<name type="synonym">SPT5H</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Genomics" volume="38" first="421" last="424">
<title>Isolation, sequencing, and mapping of the human homologue of the yeast transcription factor, SPT5.</title>
<authorList>
<person name="Chiang P.-W."/>
<person name="Fogel E."/>
<person name="Jackson C.L."/>
<person name="Lieuallen K."/>
<person name="Lennon G."/>
<person name="Qu X."/>
<person name="Wang S.-Q."/>
<person name="Kurnit D.M."/>
</authorList>
<dbReference type="PubMed" id="8975720"/>
<dbReference type="DOI" id="10.1006/geno.1996.0646"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="FEBS Lett." volume="409" first="74" last="78">
<title>Human Supt5h protein, a putative modulator of chromatin structure, is reversibly phosphorylated in mitosis.</title>
<authorList>
<person name="Stachora A.A."/>
<person name="Schaefer R.E."/>
<person name="Pohlmeier M."/>
<person name="Maier G."/>
<person name="Ponstingl H."/>
</authorList>
<dbReference type="PubMed" id="9199507"/>
<dbReference type="DOI" id="10.1016/s0014-5793(97)00486-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PROTEIN SEQUENCE OF 116-152; 288-319; 461-471; 529-542; 580-587; 746-761; 795-809; 841-885; 888-922 AND 1068-1087</scope>
<scope>DOMAINS CTR1 AND CTR2</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1998" name="Genes Dev." volume="12" first="343" last="356">
<title>DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs.</title>
<authorList>
<person name="Wada T."/>
<person name="Takagi T."/>
<person name="Yamaguchi Y."/>
<person name="Ferdous A."/>
<person name="Imai T."/>
<person name="Hirose S."/>
<person name="Sugimoto S."/>
<person name="Yano K."/>
<person name="Hartzog G.A."/>
<person name="Winston F."/>
<person name="Buratowski S."/>
<person name="Handa H."/>
</authorList>
<dbReference type="PubMed" id="9450929"/>
<dbReference type="DOI" id="10.1101/gad.12.3.343"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PROTEIN SEQUENCE OF 277-282; 324-328; 459-470 AND 580-597</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SUPT4H1 AND RNA POLYMERASE II</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1998" name="J. Mol. Biol." volume="277" first="179" last="197">
<title>Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation.</title>
<authorList>
<person name="Wu-Baer F."/>
<person name="Lane W.S."/>
<person name="Gaynor R.B."/>
</authorList>
<dbReference type="PubMed" id="9514752"/>
<dbReference type="DOI" id="10.1006/jmbi.1997.1601"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PROTEIN SEQUENCE OF 199-213; 247-258 AND 799-811</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno R.F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Muscle</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="EMBO J." volume="17" first="7395" last="7403">
<title>Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro.</title>
<authorList>
<person name="Wada T."/>
<person name="Takagi T."/>
<person name="Yamaguchi Y."/>
<person name="Watanabe D."/>
<person name="Handa H."/>
</authorList>
<dbReference type="PubMed" id="9857195"/>
<dbReference type="DOI" id="10.1093/emboj/17.24.7395"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RNA POLYMERASE II</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="Cell" volume="97" first="41" last="51">
<title>NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation.</title>
<authorList>
<person name="Yamaguchi Y."/>
<person name="Takagi T."/>
<person name="Wada T."/>
<person name="Yano K."/>
<person name="Furuya A."/>
<person name="Sugimoto S."/>
<person name="Hasegawa J."/>
<person name="Handa H."/>
</authorList>
<dbReference type="PubMed" id="10199401"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)80713-8"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH THE NELF COMPLEX</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="3688" last="3701">
<title>A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription.</title>
<authorList>
<person name="Parada C.A."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="10393184"/>
<dbReference type="DOI" id="10.1093/emboj/18.13.3688"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH NCL; CCNT1; RNA POL II; HTATSF1 AND CDK9</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Genes Dev." volume="13" first="1774" last="1779">
<title>Transcription elongation factor hSPT5 stimulates mRNA capping.</title>
<authorList>
<person name="Wen Y."/>
<person name="Shatkin A.J."/>
</authorList>
<dbReference type="PubMed" id="10421630"/>
<dbReference type="DOI" id="10.1101/gad.13.14.1774"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RNGTT</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="8085" last="8092">
<title>Structure and function of the human transcription elongation factor DSIF.</title>
<authorList>
<person name="Yamaguchi Y."/>
<person name="Wada T."/>
<person name="Watanabe D."/>
<person name="Takagi T."/>
<person name="Hasegawa J."/>
<person name="Handa H."/>
</authorList>
<dbReference type="PubMed" id="10075709"/>
<dbReference type="DOI" id="10.1074/jbc.274.12.8085"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RNA POLYMERASE II AND SUPT4H1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="5960" last="5968">
<title>Tat-SF1 protein associates with RAP30 and human SPT5 proteins.</title>
<authorList>
<person name="Kim J.B."/>
<person name="Yamaguchi Y."/>
<person name="Wada T."/>
<person name="Handa H."/>
<person name="Sharp P.A."/>
</authorList>
<dbReference type="PubMed" id="10454543"/>
<dbReference type="DOI" id="10.1128/mcb.19.9.5960"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HTATSF1 AND RNA POLYMERASE II</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Mol. Cell" volume="5" first="1067" last="1072">
<title>FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH.</title>
<authorList>
<person name="Wada T."/>
<person name="Orphanides G."/>
<person name="Hasegawa J."/>
<person name="Kim D.-K."/>
<person name="Shima D."/>
<person name="Yamaguchi Y."/>
<person name="Fukuda A."/>
<person name="Hisatake K."/>
<person name="Oh S."/>
<person name="Reinberg D."/>
<person name="Handa H."/>
</authorList>
<dbReference type="PubMed" id="10912001"/>
<dbReference type="DOI" id="10.1016/s1097-2765(00)80272-5"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="2970" last="2983">
<title>Domains in the SPT5 protein that modulate its transcriptional regulatory properties.</title>
<authorList>
<person name="Ivanov D."/>
<person name="Kwak Y.T."/>
<person name="Guo J."/>
<person name="Gaynor R.B."/>
</authorList>
<dbReference type="PubMed" id="10757782"/>
<dbReference type="DOI" id="10.1128/mcb.20.9.2970-2983.2000"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RNA POLYMERASE II AND SUPT4H1</scope>
<scope>PHOSPHORYLATION AT THR-775 AND THR-784</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="12317" last="12323">
<title>Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase.</title>
<authorList>
<person name="Kim J.B."/>
<person name="Sharp P.A."/>
</authorList>
<dbReference type="PubMed" id="11145967"/>
<dbReference type="DOI" id="10.1074/jbc.m010908200"/>
</citation>
<scope>PHOSPHORYLATION BY CDK9</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="12951" last="12958">
<title>DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation.</title>
<authorList>
<person name="Ping Y.-H."/>
<person name="Rana T.M."/>
</authorList>
<dbReference type="PubMed" id="11112772"/>
<dbReference type="DOI" id="10.1074/jbc.m006130200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION BY CDK9</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="42601" last="42609">
<title>A highly purified RNA polymerase II elongation control system.</title>
<authorList>
<person name="Renner D.B."/>
<person name="Yamaguchi Y."/>
<person name="Wada T."/>
<person name="Handa H."/>
<person name="Price D.H."/>
</authorList>
<dbReference type="PubMed" id="11553615"/>
<dbReference type="DOI" id="10.1074/jbc.m104967200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="J. Mol. Biol." volume="312" first="675" last="685">
<title>The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9.</title>
<authorList>
<person name="Lavoie S.B."/>
<person name="Albert A.L."/>
<person name="Handa H."/>
<person name="Vincent M."/>
<person name="Bensaude O."/>
</authorList>
<dbReference type="PubMed" id="11575923"/>
<dbReference type="DOI" id="10.1006/jmbi.2001.4991"/>
</citation>
<scope>INTERACTION WITH PIN1</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="1079" last="1093">
<title>Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.</title>
<authorList>
<person name="Bourgeois C.F."/>
<person name="Kim Y.K."/>
<person name="Churcher M.J."/>
<person name="West M.J."/>
<person name="Karn J."/>
</authorList>
<dbReference type="PubMed" id="11809800"/>
<dbReference type="DOI" id="10.1128/mcb.22.4.1079-1093.2002"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION BY CDK9</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="2918" last="2927">
<title>Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA.</title>
<authorList>
<person name="Yamaguchi Y."/>
<person name="Inukai N."/>
<person name="Narita T."/>
<person name="Wada T."/>
<person name="Handa H."/>
</authorList>
<dbReference type="PubMed" id="11940650"/>
<dbReference type="DOI" id="10.1128/mcb.22.9.2918-2927.2002"/>
</citation>
<scope>INTERACTION WITH THE NELF COMPLEX</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2003" name="Genes Cells" volume="8" first="371" last="378">
<title>Structure-function analysis of human Spt4: evidence that hSpt4 and hSpt5 exert their roles in transcriptional elongation as parts of the DSIF complex.</title>
<authorList>
<person name="Kim D.-K."/>
<person name="Inukai N."/>
<person name="Yamada T."/>
<person name="Furuya A."/>
<person name="Sato H."/>
<person name="Yamaguchi Y."/>
<person name="Wada T."/>
<person name="Handa H."/>
</authorList>
<dbReference type="PubMed" id="12653964"/>
<dbReference type="DOI" id="10.1046/j.1365-2443.2003.00638.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SUPT4H1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="Mol. Cell" volume="11" first="1055" last="1066">
<title>Methylation of SPT5 regulates its interaction with RNA polymerase II and transcriptional elongation properties.</title>
<authorList>
<person name="Kwak Y.T."/>
<person name="Guo J."/>
<person name="Prajapati S."/>
<person name="Park K.-J."/>
<person name="Surabhi R.M."/>
<person name="Miller B."/>
<person name="Gehrig P."/>
<person name="Gaynor R.B."/>
</authorList>
<dbReference type="PubMed" id="12718890"/>
<dbReference type="DOI" id="10.1016/s1097-2765(03)00101-1"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CDK9; PRMT1; RNA POLYMERASE II; PRMT5 AND SUPT4H1</scope>
<scope>METHYLATION AT ARG-681; ARG-696 AND ARG-698</scope>
<scope>MUTAGENESIS OF ARG-681; ARG-696 AND ARG-698</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="1863" last="1873">
<title>Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex.</title>
<authorList>
<person name="Narita T."/>
<person name="Yamaguchi Y."/>
<person name="Yano K."/>
<person name="Sugimoto S."/>
<person name="Chanarat S."/>
<person name="Wada T."/>
<person name="Kim D.-K."/>
<person name="Hasegawa J."/>
<person name="Omori M."/>
<person name="Inukai N."/>
<person name="Endoh M."/>
<person name="Yamada T."/>
<person name="Handa H."/>
</authorList>
<dbReference type="PubMed" id="12612062"/>
<dbReference type="DOI" id="10.1128/mcb.23.6.1863-1873.2003"/>
</citation>
<scope>INTERACTION WITH THE NELF COMPLEX</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="Curr. Biol." volume="14" first="1680" last="1684">
<title>Locus-specific requirements for Spt5 in transcriptional activation and repression in Drosophila.</title>
<authorList>
<person name="Jennings B.H."/>
<person name="Shah S."/>
<person name="Yamaguchi Y."/>
<person name="Seki M."/>
<person name="Phillips R.G."/>
<person name="Handa H."/>
<person name="Ish-Horowicz D."/>
</authorList>
<dbReference type="PubMed" id="15380072"/>
<dbReference type="DOI" id="10.1016/j.cub.2004.08.066"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF GLY-1002</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="J. Virol." volume="78" first="13522" last="13533">
<title>Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.</title>
<authorList>
<person name="Zhou M."/>
<person name="Deng L."/>
<person name="Lacoste V."/>
<person name="Park H.U."/>
<person name="Pumfery A."/>
<person name="Kashanchi F."/>
<person name="Brady J.N."/>
<person name="Kumar A."/>
</authorList>
<dbReference type="PubMed" id="15564463"/>
<dbReference type="DOI" id="10.1128/jvi.78.24.13522-13533.2004"/>
</citation>
<scope>PHOSPHORYLATION BY CDK9</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="787" last="795">
<title>Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element.</title>
<authorList>
<person name="Fujinaga K."/>
<person name="Irwin D."/>
<person name="Huang Y."/>
<person name="Taube R."/>
<person name="Kurosu T."/>
<person name="Peterlin B.M."/>
</authorList>
<dbReference type="PubMed" id="14701750"/>
<dbReference type="DOI" id="10.1128/mcb.24.2.787-795.2004"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="3324" last="3336">
<title>Human Spt6 stimulates transcription elongation by RNA polymerase II in vitro.</title>
<authorList>
<person name="Endoh M."/>
<person name="Zhu W."/>
<person name="Hasegawa J."/>
<person name="Watanabe H."/>
<person name="Kim D.-K."/>
<person name="Aida M."/>
<person name="Inukai N."/>
<person name="Narita T."/>
<person name="Yamada T."/>
<person name="Furuya A."/>
<person name="Sato H."/>
<person name="Yamaguchi Y."/>
<person name="Mandal S.S."/>
<person name="Reinberg D."/>
<person name="Wada T."/>
<person name="Handa H."/>
</authorList>
<dbReference type="PubMed" id="15060154"/>
<dbReference type="DOI" id="10.1128/mcb.24.8.3324-3336.2004"/>
</citation>
<scope>INTERACTION WITH RNA POLYMERASE II; SUPT4H1 AND SUPT6H</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="7572" last="7577">
<title>Functional interactions of RNA-capping enzyme with factors that positively and negatively regulate promoter escape by RNA polymerase II.</title>
<authorList>
<person name="Mandal S.S."/>
<person name="Chu C."/>
<person name="Wada T."/>
<person name="Handa H."/>
<person name="Shatkin A.J."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="15136722"/>
<dbReference type="DOI" id="10.1073/pnas.0401493101"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="15036" last="15041">
<title>A negative elongation factor for human RNA polymerase II inhibits the anti-arrest transcript-cleavage factor TFIIS.</title>
<authorList>
<person name="Palangat M."/>
<person name="Renner D.B."/>
<person name="Price D.H."/>
<person name="Landick R."/>
</authorList>
<dbReference type="PubMed" id="16214896"/>
<dbReference type="DOI" id="10.1073/pnas.0409405102"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-666</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Nat. Struct. Mol. Biol." volume="13" first="55" last="62">
<title>Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics.</title>
<authorList>
<person name="Larochelle S."/>
<person name="Batliner J."/>
<person name="Gamble M.J."/>
<person name="Barboza N.M."/>
<person name="Kraybill B.C."/>
<person name="Blethrow J.D."/>
<person name="Shokat K.M."/>
<person name="Fisher R.P."/>
</authorList>
<dbReference type="PubMed" id="16327805"/>
<dbReference type="DOI" id="10.1038/nsmb1028"/>
</citation>
<scope>PHOSPHORYLATION BY CDK7</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-666 AND THR-1034</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-666 AND THR-1034</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-666; SER-686; SER-789; THR-791; SER-804; THR-806 AND THR-1034</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2013" name="Nat. Commun." volume="4" first="1830" last="1830">
<title>GANP regulates recruitment of AID to immunoglobulin variable regions by modulating transcription and nucleosome occupancy.</title>
<authorList>
<person name="Singh S.K."/>
<person name="Maeda K."/>
<person name="Eid M.M."/>
<person name="Almofty S.A."/>
<person name="Ono M."/>
<person name="Pham P."/>
<person name="Goodman M.F."/>
<person name="Sakaguchi N."/>
</authorList>
<dbReference type="PubMed" id="23652018"/>
<dbReference type="DOI" id="10.1038/ncomms2823"/>
</citation>
<scope>INTERACTION WITH MCM3AP</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-143</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-143</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-143 AND LYS-1037</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="submission" date="2007-07" db="PDB data bank">
<title>Solution structure of KOW motifs of human transcription elongation factor SPT5.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 420-523 AND 690-757</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2010" name="Biochem. J." volume="425" first="373" last="380">
<title>Crystal structure of the human transcription elongation factor DSIF hSpt4 subunit in complex with the hSpt5 dimerization interface.</title>
<authorList>
<person name="Wenzel S."/>
<person name="Martins B.M."/>
<person name="Rosch P."/>
<person name="Wohrl B.M."/>
</authorList>
<dbReference type="PubMed" id="19860741"/>
<dbReference type="DOI" id="10.1042/bj20091422"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 176-273 IN COMPLEX WITH SPT4H1</scope>
</reference>
<comment type="function">
<text evidence="15 16 17 18 19 20 21 22 24 26 29 30 31 33 34 36 42 43 44">Component of the DRB sensitivity-inducing factor complex (DSIF complex), which regulates mRNA processing and transcription elongation by RNA polymerase II. DSIF positively regulates mRNA capping by stimulating the mRNA guanylyltransferase activity of RNGTT/CAP1A. DSIF also acts cooperatively with the negative elongation factor complex (NELF complex) to enhance transcriptional pausing at sites proximal to the promoter. Transcriptional pausing may facilitate the assembly of an elongation competent RNA polymerase II complex. DSIF and NELF promote pausing by inhibition of the transcription elongation factor TFIIS/S-II. TFIIS/S-II binds to RNA polymerase II at transcription pause sites and stimulates the weak intrinsic nuclease activity of the enzyme. Cleavage of blocked transcripts by RNA polymerase II promotes the resumption of transcription from the new 3' terminus and may allow repeated attempts at transcription through natural pause sites. DSIF can also positively regulate transcriptional elongation and is required for the efficient activation of transcriptional elongation by the HIV-1 nuclear transcriptional activator, Tat. DSIF acts to suppress transcriptional pausing in transcripts derived from the HIV-1 LTR and blocks premature release of HIV-1 transcripts at terminator sequences.</text>
</comment>
<comment type="subunit">
<text evidence="15 16 17 18 19 20 25 27 28 29 30 32 38 39 42 44">Interacts with SUPT4H1 to form DSIF. DSIF interacts with the positive transcription elongation factor b complex (P-TEFb complex), which is composed of CDK9 and cyclin-T (CCNT1 or CCNT2). DSIF interacts with RNA polymerase II, and this interaction is reduced by phosphorylation of the C-terminal domain (CTD) of POLR2A by P-TEFb. DSIF also interacts with the NELF complex, which is composed of NELFA, NELFB, NELFD and NELFE, and this interaction occurs following prior binding of DSIF to RNA polymerase II. DSIF also interacts with PRMT1/HRMT1L2, HTATSF1/TATSF1, RNGTT/CAP1A, PRMT5/SKB1, SUPT6H, and can interact with PIN1. Component of a complex which is at least composed of HTATSF1/Tat-SF1, the P-TEFb complex components CDK9 and CCNT1, RNA polymerase II, SUPT5H, and NCL/nucleolin. Interacts with MCM3AP isoform GANP (PubMed:23652018).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-710464">
<id>O00267</id>
</interactant>
<interactant intactId="EBI-1245958">
<id>P50613</id>
<label>CDK7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-710464">
<id>O00267</id>
</interactant>
<interactant intactId="EBI-714158">
<id>Q13526</id>
<label>PIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-710464">
<id>O00267</id>
</interactant>
<interactant intactId="EBI-295301">
<id>P24928</id>
<label>POLR2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-710464">
<id>O00267</id>
</interactant>
<interactant intactId="EBI-437708">
<id>P62937</id>
<label>PPIA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-710464">
<id>O00267</id>
</interactant>
<interactant intactId="EBI-727250">
<id>P63272</id>
<label>SUPT4H1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-710464">
<id>O00267</id>
</interactant>
<interactant intactId="EBI-710997">
<id>P54274</id>
<label>TERF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-710464">
<id>O00267</id>
</interactant>
<interactant intactId="EBI-6551200">
<id>G3MZY8</id>
<label>POLR2A</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-710464">
<id>O00267</id>
</interactant>
<interactant intactId="EBI-15586776">
<id>A5PJW8</id>
<label>POLR2B</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="15">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O00267-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O00267-2</id>
<name>2</name>
<sequence type="described" ref="VSP_016282"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="15 40">Ubiquitously expressed.</text>
</comment>
<comment type="PTM">
<text evidence="30">Methylated by PRMT1/HRMT1L2 and PRMT5/SKB1. Methylation negatively regulates interaction with P-TEFb and RNA polymerase II.</text>
</comment>
<comment type="PTM">
<text evidence="20 22 23 25 26 35 37 41">Phosphorylated by CDK7 and CDK9. Phosphorylation by P-TEFb alleviates transcriptional pausing and can stimulate transcriptional elongation from the HIV-1 LTR. P-TEFb dependent phosphorylation is stimulated by the HIV-1 Tat protein. Phosphorylation may also stimulate interaction with PIN1. Bulk phosphorylation occurs predominantly in mitosis.</text>
</comment>
<comment type="similarity">
<text evidence="46">Belongs to the SPT5 family.</text>
</comment>
<comment type="sequence caution" evidence="46">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAD92494" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="U56402">
<property type="protein sequence ID" value="AAC51102.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Y12790">
<property type="protein sequence ID" value="CAA73326.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB000516">
<property type="protein sequence ID" value="BAA24075.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF040253">
<property type="protein sequence ID" value="AAD02179.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB209257">
<property type="protein sequence ID" value="BAD92494.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC024203">
<property type="protein sequence ID" value="AAH24203.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12536.1">
<molecule id="O00267-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46072.1">
<molecule id="O00267-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001104490.1">
<molecule id="O00267-1"/>
<property type="nucleotide sequence ID" value="NM_001111020.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001124296.1">
<molecule id="O00267-1"/>
<property type="nucleotide sequence ID" value="NM_001130824.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001124297.1">
<molecule id="O00267-2"/>
<property type="nucleotide sequence ID" value="NM_001130825.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001306919.1">
<molecule id="O00267-1"/>
<property type="nucleotide sequence ID" value="NM_001319990.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001306920.1">
<molecule id="O00267-2"/>
<property type="nucleotide sequence ID" value="NM_001319991.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003160.2">
<molecule id="O00267-1"/>
<property type="nucleotide sequence ID" value="NM_003169.3"/>
</dbReference>
<dbReference type="PDB" id="2DO3">
<property type="method" value="NMR"/>
<property type="chains" value="A=462-523"/>
</dbReference>
<dbReference type="PDB" id="2E6Z">
<property type="method" value="NMR"/>
<property type="chains" value="A=420-471"/>
</dbReference>
<dbReference type="PDB" id="2E70">
<property type="method" value="NMR"/>
<property type="chains" value="A=694-757"/>
</dbReference>
<dbReference type="PDB" id="3H7H">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="B=176-273"/>
</dbReference>
<dbReference type="PDB" id="4L1U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.42"/>
<property type="chains" value="G/H/I/J=778-790"/>
</dbReference>
<dbReference type="PDB" id="5OHO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A/B=536-646"/>
</dbReference>
<dbReference type="PDB" id="5OHQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.10"/>
<property type="chains" value="A=979-1087"/>
</dbReference>
<dbReference type="PDB" id="5OIK">
<property type="method" value="EM"/>
<property type="resolution" value="3.70"/>
<property type="chains" value="Z=1-1087"/>
</dbReference>
<dbReference type="PDB" id="5U98">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="C/F=980-988"/>
</dbReference>
<dbReference type="PDB" id="6EQY">
<property type="method" value="NMR"/>
<property type="chains" value="A=522-647"/>
</dbReference>
<dbReference type="PDB" id="6ER0">
<property type="method" value="NMR"/>
<property type="chains" value="A=961-1087"/>
</dbReference>
<dbReference type="PDB" id="6GMH">
<property type="method" value="EM"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="Z=1-1087"/>
</dbReference>
<dbReference type="PDB" id="6GML">
<property type="method" value="EM"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="Z=1-1087"/>
</dbReference>
<dbReference type="PDB" id="6TED">
<property type="method" value="EM"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="Z=1-1087"/>
</dbReference>
<dbReference type="PDBsum" id="2DO3"/>
<dbReference type="PDBsum" id="2E6Z"/>
<dbReference type="PDBsum" id="2E70"/>
<dbReference type="PDBsum" id="3H7H"/>
<dbReference type="PDBsum" id="4L1U"/>
<dbReference type="PDBsum" id="5OHO"/>
<dbReference type="PDBsum" id="5OHQ"/>
<dbReference type="PDBsum" id="5OIK"/>
<dbReference type="PDBsum" id="5U98"/>
<dbReference type="PDBsum" id="6EQY"/>
<dbReference type="PDBsum" id="6ER0"/>
<dbReference type="PDBsum" id="6GMH"/>
<dbReference type="PDBsum" id="6GML"/>
<dbReference type="PDBsum" id="6TED"/>
<dbReference type="SMR" id="O00267"/>
<dbReference type="BioGRID" id="112697">
<property type="interactions" value="171"/>
</dbReference>
<dbReference type="CORUM" id="O00267"/>
<dbReference type="DIP" id="DIP-29014N"/>
<dbReference type="IntAct" id="O00267">
<property type="interactions" value="96"/>
</dbReference>
<dbReference type="MINT" id="O00267"/>
<dbReference type="STRING" id="9606.ENSP00000470252"/>
<dbReference type="iPTMnet" id="O00267"/>
<dbReference type="MetOSite" id="O00267"/>
<dbReference type="PhosphoSitePlus" id="O00267"/>
<dbReference type="BioMuta" id="SUPT5H"/>
<dbReference type="EPD" id="O00267"/>
<dbReference type="jPOST" id="O00267"/>
<dbReference type="MassIVE" id="O00267"/>
<dbReference type="MaxQB" id="O00267"/>
<dbReference type="PaxDb" id="O00267"/>
<dbReference type="PeptideAtlas" id="O00267"/>
<dbReference type="PRIDE" id="O00267"/>
<dbReference type="ProteomicsDB" id="47816">
<molecule id="O00267-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="47817">
<molecule id="O00267-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="16797">
<property type="antibodies" value="173 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="6829"/>
<dbReference type="Ensembl" id="ENST00000359191">
<molecule id="O00267-2"/>
<property type="protein sequence ID" value="ENSP00000352117"/>
<property type="gene ID" value="ENSG00000196235"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000402194">
<molecule id="O00267-2"/>
<property type="protein sequence ID" value="ENSP00000384505"/>
<property type="gene ID" value="ENSG00000196235"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000432763">
<molecule id="O00267-1"/>
<property type="protein sequence ID" value="ENSP00000404029"/>
<property type="gene ID" value="ENSG00000196235"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000598725">
<molecule id="O00267-1"/>
<property type="protein sequence ID" value="ENSP00000469090"/>
<property type="gene ID" value="ENSG00000196235"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000599117">
<molecule id="O00267-1"/>
<property type="protein sequence ID" value="ENSP00000470252"/>
<property type="gene ID" value="ENSG00000196235"/>
</dbReference>
<dbReference type="GeneID" id="6829"/>
<dbReference type="KEGG" id="hsa:6829"/>
<dbReference type="UCSC" id="uc002olo.5">
<molecule id="O00267-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6829"/>
<dbReference type="DisGeNET" id="6829"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000196235.13"/>
<dbReference type="GeneCards" id="SUPT5H"/>
<dbReference type="HGNC" id="HGNC:11469">
<property type="gene designation" value="SUPT5H"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000196235">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="602102">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O00267"/>
<dbReference type="OpenTargets" id="ENSG00000196235"/>
<dbReference type="PharmGKB" id="PA36255"/>
<dbReference type="eggNOG" id="KOG1999">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00440000037640"/>
<dbReference type="HOGENOM" id="CLU_003537_0_0_1"/>
<dbReference type="InParanoid" id="O00267"/>
<dbReference type="KO" id="K15172"/>
<dbReference type="OMA" id="GYMNTPS"/>
<dbReference type="OrthoDB" id="828863at2759"/>
<dbReference type="PhylomeDB" id="O00267"/>
<dbReference type="TreeFam" id="TF105730"/>
<dbReference type="BioCyc" id="MetaCyc:G66-31601-MONOMER"/>
<dbReference type="PathwayCommons" id="O00267"/>
<dbReference type="Reactome" id="R-HSA-112382">
<property type="pathway name" value="Formation of RNA Pol II elongation complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-113418">
<property type="pathway name" value="Formation of the Early Elongation Complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167152">
<property type="pathway name" value="Formation of HIV elongation complex in the absence of HIV Tat"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167158">
<property type="pathway name" value="Formation of the HIV-1 Early Elongation Complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167160">
<property type="pathway name" value="RNA Pol II CTD phosphorylation and interaction with CE during HIV infection"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167200">
<property type="pathway name" value="Formation of HIV-1 elongation complex containing HIV-1 Tat"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167238">
<property type="pathway name" value="Pausing and recovery of Tat-mediated HIV elongation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167242">
<property type="pathway name" value="Abortive elongation of HIV-1 transcript in the absence of Tat"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167243">
<property type="pathway name" value="Tat-mediated HIV elongation arrest and recovery"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167246">
<property type="pathway name" value="Tat-mediated elongation of the HIV-1 transcript"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167287">
<property type="pathway name" value="HIV elongation arrest and recovery"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167290">
<property type="pathway name" value="Pausing and recovery of HIV elongation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-674695">
<property type="pathway name" value="RNA Polymerase II Pre-transcription Events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6796648">
<property type="pathway name" value="TP53 Regulates Transcription of DNA Repair Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6807505">
<property type="pathway name" value="RNA polymerase II transcribes snRNA genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-72086">
<property type="pathway name" value="mRNA Capping"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75955">
<property type="pathway name" value="RNA Polymerase II Transcription Elongation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-77075">
<property type="pathway name" value="RNA Pol II CTD phosphorylation and interaction with CE"/>
</dbReference>
<dbReference type="SIGNOR" id="O00267"/>
<dbReference type="BioGRID-ORCS" id="6829">
<property type="hits" value="692 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SUPT5H">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O00267"/>
<dbReference type="GeneWiki" id="SUPT5H"/>
<dbReference type="GenomeRNAi" id="6829"/>
<dbReference type="Pharos" id="O00267">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O00267"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="O00267">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000196235">
<property type="expression patterns" value="Expressed in testis and 239 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O00267">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O00267">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0032044">
<property type="term" value="C:DSIF complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003729">
<property type="term" value="F:mRNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006370">
<property type="term" value="P:7-methylguanosine mRNA capping"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032785">
<property type="term" value="P:negative regulation of DNA-templated transcription, elongation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900364">
<property type="term" value="P:negative regulation of mRNA polyadenylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032786">
<property type="term" value="P:positive regulation of DNA-templated transcription, elongation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016239">
<property type="term" value="P:positive regulation of macroautophagy"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050434">
<property type="term" value="P:positive regulation of viral transcription"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006366">
<property type="term" value="P:transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006368">
<property type="term" value="P:transcription elongation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd06081">
<property type="entry name" value="KOW_Spt5_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd06082">
<property type="entry name" value="KOW_Spt5_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd06083">
<property type="entry name" value="KOW_Spt5_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd06084">
<property type="entry name" value="KOW_Spt5_4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd06085">
<property type="entry name" value="KOW_Spt5_5"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd06086">
<property type="entry name" value="KOW_Spt5_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd09888">
<property type="entry name" value="NGN_Euk"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.30.30">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.70.940">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00641"/>
<dbReference type="InterPro" id="IPR005824">
<property type="entry name" value="KOW"/>
</dbReference>
<dbReference type="InterPro" id="IPR041973">
<property type="entry name" value="KOW_Spt5_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR041975">
<property type="entry name" value="KOW_Spt5_2"/>
</dbReference>
<dbReference type="InterPro" id="IPR041976">
<property type="entry name" value="KOW_Spt5_3"/>
</dbReference>
<dbReference type="InterPro" id="IPR041977">
<property type="entry name" value="KOW_Spt5_4"/>
</dbReference>
<dbReference type="InterPro" id="IPR041978">
<property type="entry name" value="KOW_Spt5_5"/>
</dbReference>
<dbReference type="InterPro" id="IPR041980">
<property type="entry name" value="KOW_Spt5_6"/>
</dbReference>
<dbReference type="InterPro" id="IPR005100">
<property type="entry name" value="NGN-domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR006645">
<property type="entry name" value="NGN_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036735">
<property type="entry name" value="NGN_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR039385">
<property type="entry name" value="NGN_Euk"/>
</dbReference>
<dbReference type="InterPro" id="IPR014722">
<property type="entry name" value="Rib_L2_dom2"/>
</dbReference>
<dbReference type="InterPro" id="IPR039659">
<property type="entry name" value="SPT5"/>
</dbReference>
<dbReference type="InterPro" id="IPR024945">
<property type="entry name" value="Spt5_C_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR022581">
<property type="entry name" value="Spt5_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR017071">
<property type="entry name" value="TF_Spt5_eukaryote"/>
</dbReference>
<dbReference type="InterPro" id="IPR008991">
<property type="entry name" value="Translation_prot_SH3-like_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11125">
<property type="entry name" value="PTHR11125"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00467">
<property type="entry name" value="KOW"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03439">
<property type="entry name" value="Spt5-NGN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF11942">
<property type="entry name" value="Spt5_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF036945">
<property type="entry name" value="Spt5"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01104">
<property type="entry name" value="CTD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00739">
<property type="entry name" value="KOW"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00738">
<property type="entry name" value="NGN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50104">
<property type="entry name" value="SSF50104"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Transcription elongation factor SPT5" id="PRO_0000208468">
<location>
<begin position="1"/>
<end position="1087"/>
</location>
</feature>
<feature type="domain" description="KOW 1">
<location>
<begin position="273"/>
<end position="306"/>
</location>
</feature>
<feature type="domain" description="KOW 2">
<location>
<begin position="420"/>
<end position="451"/>
</location>
</feature>
<feature type="domain" description="KOW 3">
<location>
<begin position="472"/>
<end position="503"/>
</location>
</feature>
<feature type="domain" description="KOW 4">
<location>
<begin position="594"/>
<end position="627"/>
</location>
</feature>
<feature type="domain" description="KOW 5">
<location>
<begin position="704"/>
<end position="737"/>
</location>
</feature>
<feature type="repeat" description="CTR1-1; approximate">
<location>
<begin position="754"/>
<end position="759"/>
</location>
</feature>
<feature type="repeat" description="CTR1-2">
<location>
<begin position="760"/>
<end position="765"/>
</location>
</feature>
<feature type="repeat" description="CTR1-3">
<location>
<begin position="766"/>
<end position="771"/>
</location>
</feature>
<feature type="repeat" description="CTR1-4">
<location>
<begin position="772"/>
<end position="778"/>
</location>
</feature>
<feature type="repeat" description="CTR1-5">
<location>
<begin position="781"/>
<end position="787"/>
</location>
</feature>
<feature type="repeat" description="CTR1-6">
<location>
<begin position="788"/>
<end position="794"/>
</location>
</feature>
<feature type="repeat" description="CTR1-7">
<location>
<begin position="796"/>
<end position="802"/>
</location>
</feature>
<feature type="repeat" description="CTR1-8">
<location>
<begin position="803"/>
<end position="809"/>
</location>
</feature>
<feature type="repeat" description="CTR1-9">
<location>
<begin position="811"/>
<end position="817"/>
</location>
</feature>
<feature type="repeat" description="CTR2-1">
<location>
<begin position="844"/>
<end position="851"/>
</location>
</feature>
<feature type="repeat" description="CTR2-2; approximate">
<location>
<begin position="854"/>
<end position="862"/>
</location>
</feature>
<feature type="repeat" description="CTR2-3; approximate">
<location>
<begin position="863"/>
<end position="869"/>
</location>
</feature>
<feature type="repeat" description="CTR2-4; half-length">
<location>
<begin position="881"/>
<end position="885"/>
</location>
</feature>
<feature type="repeat" description="CTR2-5; approximate">
<location>
<begin position="896"/>
<end position="902"/>
</location>
</feature>
<feature type="repeat" description="CTR2-6">
<location>
<begin position="904"/>
<end position="911"/>
</location>
</feature>
<feature type="repeat" description="CTR2-7; approximate">
<location>
<begin position="916"/>
<end position="921"/>
</location>
</feature>
<feature type="repeat" description="CTR2-8">
<location>
<begin position="924"/>
<end position="930"/>
</location>
</feature>
<feature type="repeat" description="CTR2-9">
<location>
<begin position="932"/>
<end position="939"/>
</location>
</feature>
<feature type="repeat" description="CTR2-10">
<location>
<begin position="943"/>
<end position="950"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SUPT4H1">
<location>
<begin position="176"/>
<end position="270"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RNA polymerase II">
<location>
<begin position="313"/>
<end position="420"/>
</location>
</feature>
<feature type="region of interest" description="9 X 7 AA approximate tandem repeats of G-S-[QR]-T-P-X-[YQ], motif CTR1">
<location>
<begin position="754"/>
<end position="817"/>
</location>
</feature>
<feature type="region of interest" description="10 X 8 AA approximate tandem repeats of P-[TS]-P-S-P-[QA]-[SG]-Y, motif CTR2">
<location>
<begin position="844"/>
<end position="950"/>
</location>
</feature>
<feature type="compositionally biased region" description="Glu-rich">
<location>
<begin position="11"/>
<end position="106"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="844"/>
<end position="968"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="32"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="36"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 8 9 10">
<location>
<position position="666"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT1; alternate" evidence="30">
<location>
<position position="681"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; by PRMT1; alternate" evidence="30">
<location>
<position position="681"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="686"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT1; alternate" evidence="30">
<location>
<position position="696"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; by PRMT1; alternate" evidence="30">
<location>
<position position="696"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT1; alternate" evidence="30">
<location>
<position position="698"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; by PRMT1 and PRMT5; alternate" evidence="30">
<location>
<position position="698"/>
</location>
</feature>
<feature type="modified residue" description="Symmetric dimethylarginine; by PRMT5; alternate" evidence="30">
<location>
<position position="698"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="718"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK9" evidence="20">
<location>
<position position="775"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK9" evidence="20">
<location>
<position position="784"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="789"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="791"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="804"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="806"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8 9 10">
<location>
<position position="1034"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="11 12 13">
<location>
<position position="143"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="13">
<location>
<position position="1037"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_016282" evidence="45">
<location>
<begin position="103"/>
<end position="106"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances interactions with CDK9 and RNA polymerase II and enhances transcriptional elongation; when associated with A-696 and A-698." evidence="30">
<original>R</original>
<variation>A</variation>
<location>
<position position="681"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases promoter association and enhances transcriptional elongation; when associated with K-696 and K-698." evidence="30">
<original>R</original>
<variation>K</variation>
<location>
<position position="681"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances interactions with CDK9 and RNA polymerase II and enhances transcriptional elongation; when associated with A-681 and A-698." evidence="30">
<original>R</original>
<variation>A</variation>
<location>
<position position="696"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases promoter association and enhances transcriptional elongation; when associated with K-681 and K-698." evidence="30">
<original>R</original>
<variation>K</variation>
<location>
<position position="696"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances transcriptional elongation. Enhances interactions with CDK9 and RNA polymerase II and enhances transcriptional elongation; when associated with A-681 and A-696." evidence="30">
<original>R</original>
<variation>A</variation>
<location>
<position position="698"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases promoter association and enhances transcriptional elongation; when associated with K-681 and K-696." evidence="30">
<original>R</original>
<variation>K</variation>
<location>
<position position="698"/>
</location>
</feature>
<feature type="mutagenesis site" description="Defective in regulation of transcriptional elongation." evidence="34">
<original>G</original>
<variation>D</variation>
<location>
<position position="1002"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC51102." ref="1" evidence="46">
<original>T</original>
<variation>I</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC51102." ref="1" evidence="46">
<original>G</original>
<variation>A</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC51102." ref="1" evidence="46">
<original>A</original>
<variation>G</variation>
<location>
<position position="820"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAA24075." ref="3" evidence="46">
<original>P</original>
<variation>R</variation>
<location>
<position position="846"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="178"/>
<end position="183"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="189"/>
<end position="203"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="206"/>
<end position="208"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="214"/>
<end position="217"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="223"/>
<end position="231"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="232"/>
<end position="239"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="243"/>
<end position="248"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="257"/>
<end position="259"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="262"/>
<end position="264"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="278"/>
<end position="284"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="290"/>
<end position="296"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="300"/>
<end position="307"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="313"/>
<end position="315"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="342"/>
<end position="348"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="350"/>
<end position="355"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="358"/>
<end position="361"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="362"/>
<end position="364"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="365"/>
<end position="368"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="371"/>
<end position="378"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="390"/>
<end position="395"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="425"/>
<end position="428"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="432"/>
<end position="435"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="437"/>
<end position="439"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="445"/>
<end position="447"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="461"/>
<end position="464"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="465"/>
<end position="467"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="468"/>
<end position="470"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="477"/>
<end position="480"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="484"/>
<end position="487"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="489"/>
<end position="495"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="500"/>
<end position="507"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="510"/>
<end position="513"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="515"/>
<end position="517"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="518"/>
<end position="520"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="531"/>
<end position="533"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="539"/>
<end position="541"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="543"/>
<end position="545"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="547"/>
<end position="553"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="555"/>
<end position="562"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="563"/>
<end position="565"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="567"/>
<end position="571"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="572"/>
<end position="574"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="575"/>
<end position="577"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="585"/>
<end position="587"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="589"/>
<end position="591"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="593"/>
<end position="595"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="599"/>
<end position="602"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="606"/>
<end position="609"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="611"/>
<end position="617"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="619"/>
<end position="625"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="631"/>
<end position="634"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="635"/>
<end position="639"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="640"/>
<end position="642"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="643"/>
<end position="645"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="709"/>
<end position="712"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="716"/>
<end position="719"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="721"/>
<end position="727"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="729"/>
<end position="740"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="742"/>
<end position="746"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="747"/>
<end position="749"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="750"/>
<end position="752"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="984"/>
<end position="988"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="995"/>
<end position="999"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1001"/>
<end position="1008"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1011"/>
<end position="1016"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="1017"/>
<end position="1020"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1021"/>
<end position="1026"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1027"/>
<end position="1029"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1030"/>
<end position="1032"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1040"/>
<end position="1043"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="1047"/>
<end position="1050"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1052"/>
<end position="1059"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1062"/>
<end position="1067"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="1068"/>
<end position="1070"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1073"/>
<end position="1077"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1078"/>
<end position="1080"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1081"/>
<end position="1084"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2E6Z"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3H7H"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5OHO"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5OHQ"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6EQY"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6GMH"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O55201"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10075709"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10199401"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10393184"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10421630"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10454543"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10757782"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10912001"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11112772"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11145967"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11553615"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11575923"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11809800"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11940650"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12612062"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12653964"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12718890"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14701750"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15060154"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15136722"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15380072"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15564463"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16214896"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16327805"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19860741"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23652018"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8975720"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9199507"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9450929"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9514752"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9857195"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000303">
<source ref="5"/>
</evidence>
<evidence key="46" type="ECO:0000305"/>
<sequence length="1087" mass="121000" checksum="EC3F402A670A5B7D" modified="1997-07-01" version="1">MSDSEDSNFSEEEDSERSSDGEEAEVDEERRSAAGSEKEEEPEDEEEEEEEEEYDEEEEEEDDDRPPKKPRHGGFILDEADVDDEYEDEDQWEDGAEDILEKEEIEASNIDNVVLDEDRSGARRLQNLWRDQREEELGEYYMKKYAKSSVGETVYGGSDELSDDITQQQLLPGVKDPNLWTVKCKIGEERATAISLMRKFIAYQFTDTPLQIKSVVAPEHVKGYIYVEAYKQTHVKQAIEGVGNLRLGYWNQQMVPIKEMTDVLKVVKEVANLKPKSWVRLKRGIYKDDIAQVDYVEPSQNTISLKMIPRIDYDRIKARMSLKDWFAKRKKFKRPPQRLFDAEKIRSLGGDVASDGDFLIFEGNRYSRKGFLFKSFAMSAVITEGVKPTLSELEKFEDQPEGIDLEVVTESTGKEREHNFQPGDNVEVCEGELINLQGKILSVDGNKITIMPKHEDLKDMLEFPAQELRKYFKMGDHVKVIAGRFEGDTGLIVRVEENFVILFSDLTMHELKVLPRDLQLCSETASGVDVGGQHEWGELVQLDPQTVGVIVRLERETFQVLNMYGKVVTVRHQAVTRKKDNRFAVALDSEQNNIHVKDIVKVIDGPHSGREGEIRHLFRSFAFLHCKKLVENGGMFVCKTRHLVLAGGSKPRDVTNFTVGGFAPMSPRISSPMHPSAGGQRGGFGSPGGGSGGMSRGRGRRDNELIGQTVRISQGPYKGYIGVVKDATESTARVELHSTCQTISVDRQRLTTVGSRRPGGMTSTYGRTPMYGSQTPMYGSGSRTPMYGSQTPLQDGSRTPHYGSQTPLHDGSRTPAQSGAWDPNNPNTPSRAEEEYEYAFDDEPTPSPQAYGGTPNPQTPGYPDPSSPQVNPQYNPQTPGTPAMYNTDQFSPYAAPSPQGSYQPSPSPQSYHQVAPSPAGYQNTHSPASYHPTPSPMAYQASPSPSPVGYSPMTPGAPSPGGYNPHTPGSGIEQNSSDWVTTDIQVKVRDTYLDTQVVGQTGVIRSVTGGMCSVYLKDSEKVVSISSEHLEPITPTKNNKVKVILGEDREATGVLLSIDGEDGIVRMDLDEQLKILNLRFLGKLLEA</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

